These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

376 related items for PubMed ID: 27577078

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. MiR-31 regulates the cisplatin resistance by targeting Src in gallbladder cancer.
    Li M, Chen W, Zhang H, Zhang Y, Ke F, Wu X, Zhang Y, Weng M, Liu Y, Gong W.
    Oncotarget; 2016 Dec 13; 7(50):83060-83070. PubMed ID: 27825112
    [Abstract] [Full Text] [Related]

  • 3. Downregulation of stathmin 1 in human gallbladder carcinoma inhibits tumor growth in vitro and in vivo.
    Wang J, Yao Y, Ming Y, Shen S, Wu N, Liu J, Liu H, Suo T, Pan H, Zhang D, Ding K, Liu H.
    Sci Rep; 2016 Jun 28; 6():28833. PubMed ID: 27349455
    [Abstract] [Full Text] [Related]

  • 4. Long non-coding RNA PVT1 promotes tumor progression by regulating the miR-143/HK2 axis in gallbladder cancer.
    Chen J, Yu Y, Li H, Hu Q, Chen X, He Y, Xue C, Ren F, Ren Z, Li J, Liu L, Duan Z, Cui G, Sun R.
    Mol Cancer; 2019 Mar 02; 18(1):33. PubMed ID: 30825877
    [Abstract] [Full Text] [Related]

  • 5. Overexpressed microRNA-136 works as a cancer suppressor in gallbladder cancer through suppression of JNK signaling pathway via inhibition of MAP2K4.
    Niu J, Li Z, Li F.
    Am J Physiol Gastrointest Liver Physiol; 2019 Nov 01; 317(5):G670-G681. PubMed ID: 31369289
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Knockdown of LINC01694 inhibits growth of gallbladder cancer cells via miR-340-5p/Sox4.
    Liu L, Yan Y, Zhang G, Chen C, Shen W, Xing P.
    Biosci Rep; 2020 Apr 30; 40(4):. PubMed ID: 32270853
    [Abstract] [Full Text] [Related]

  • 8. Long non-coding RNA TUG1 promotes cell proliferation and metastasis by negatively regulating miR-300 in gallbladder carcinoma.
    Ma F, Wang SH, Cai Q, Jin LY, Zhou D, Ding J, Quan ZW.
    Biomed Pharmacother; 2017 Apr 30; 88():863-869. PubMed ID: 28178615
    [Abstract] [Full Text] [Related]

  • 9. miR-193a-3p Enhanced the Chemosensitivity to Trametinib in Gallbladder Carcinoma by Targeting KRAS and Downregulating ERK Signaling.
    Yang G, Xu Q, Wan Y, Zhang L, Wang Z, Meng F.
    Cancer Biother Radiopharm; 2023 Aug 30; 38(6):371-379. PubMed ID: 34287012
    [Abstract] [Full Text] [Related]

  • 10. The lncRNA MALAT1 functions as a competing endogenous RNA to regulate MCL-1 expression by sponging miR-363-3p in gallbladder cancer.
    Wang SH, Zhang WJ, Wu XC, Weng MZ, Zhang MD, Cai Q, Zhou D, Wang JD, Quan ZW.
    J Cell Mol Med; 2016 Dec 30; 20(12):2299-2308. PubMed ID: 27420766
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Silencing SNHG1 Suppresses Viability, Proliferation and Invasion of Gallbladder Carcinoma Cells via Targeting miR-194-5p.
    Lu X, Hu K, Tan Q, Zhao K.
    Ann Clin Lab Sci; 2022 Sep 30; 52(5):707-720. PubMed ID: 36261179
    [Abstract] [Full Text] [Related]

  • 13. The microRNA miR-33a suppresses IL-6-induced tumor progression by binding Twist in gallbladder cancer.
    Zhang M, Gong W, Zuo B, Chu B, Tang Z, Zhang Y, Yang Y, Zhou D, Weng M, Qin Y, Ma M, Jiang A, Ma F, Quan Z.
    Oncotarget; 2016 Nov 29; 7(48):78640-78652. PubMed ID: 27769047
    [Abstract] [Full Text] [Related]

  • 14. MiR-1231 enhances docetaxel sensitivity to gallbladder carcinoma cells by downregulating FOXC2.
    Gong YQ, Ni JL, Fang Q, Li T.
    Eur Rev Med Pharmacol Sci; 2020 Dec 29; 24(23):12116-12123. PubMed ID: 33336729
    [Abstract] [Full Text] [Related]

  • 15. Long noncoding RNA H19 contributes to gallbladder cancer cell proliferation by modulated miR-194-5p targeting AKT2.
    Wang SH, Wu XC, Zhang MD, Weng MZ, Zhou D, Quan ZW.
    Tumour Biol; 2016 Jul 29; 37(7):9721-30. PubMed ID: 26803515
    [Abstract] [Full Text] [Related]

  • 16. Overexpression of SNORA21 suppresses tumorgenesis of gallbladder cancer in vitro and in vivo.
    Qin Y, Zhou Y, Ge A, Chang L, Shi H, Fu Y, Luo Q.
    Biomed Pharmacother; 2019 Oct 29; 118():109266. PubMed ID: 31401397
    [Abstract] [Full Text] [Related]

  • 17. miR-145 sensitizes gallbladder cancer to cisplatin by regulating multidrug resistance associated protein 1.
    Zhan M, Zhao X, Wang H, Chen W, Xu S, Wang W, Shen H, Huang S, Wang J.
    Tumour Biol; 2016 Aug 29; 37(8):10553-62. PubMed ID: 26852750
    [Abstract] [Full Text] [Related]

  • 18. Prohibitin overexpression predicts poor prognosis and promotes cell proliferation and invasion through ERK pathway activation in gallbladder cancer.
    Cao Y, Liang H, Zhang F, Luan Z, Zhao S, Wang XA, Liu S, Bao R, Shu Y, Ma Q, Zhu J, Liu Y.
    J Exp Clin Cancer Res; 2016 Apr 16; 35():68. PubMed ID: 27084680
    [Abstract] [Full Text] [Related]

  • 19. Long non-coding RNA H19 regulates FOXM1 expression by competitively binding endogenous miR-342-3p in gallbladder cancer.
    Wang SH, Ma F, Tang ZH, Wu XC, Cai Q, Zhang MD, Weng MZ, Zhou D, Wang JD, Quan ZW.
    J Exp Clin Cancer Res; 2016 Oct 03; 35(1):160. PubMed ID: 27716361
    [Abstract] [Full Text] [Related]

  • 20. miR-1 and miR-145 act as tumor suppressor microRNAs in gallbladder cancer.
    Letelier P, García P, Leal P, Álvarez H, Ili C, López J, Castillo J, Brebi P, Roa JC.
    Int J Clin Exp Pathol; 2014 Oct 03; 7(5):1849-67. PubMed ID: 24966896
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.